Agios Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Agios Pharmaceuticals, Inc.

Aug-04	Agios' PYRUKYND (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia AGIO GlobeNewswire
Jul-31	Agios Reports Second Quarter 2025 Financial Results and Provides Business Update AGIO GlobeNewswire
Jul-14	Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET AGIO GlobeNewswire
Jul-08	Agios Appoints Dr. Jay Backstrom to Board of Directors AGIO GlobeNewswire
May-28	Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 AGIO GlobeNewswire
May-14	Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress AGIO GlobeNewswire
May-09	Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025 AGIO GlobeNewswire
May-02	Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025 AGIO GlobeNewswire